Each program runs on the same integrated infrastructure and the same accredited lab, so health plans can consolidate multiple screening gaps under a single accountable partner.
At-home HPV self-collection using the FDA-approved BD Onclarity assay via Waters Corporation. Detects 14 high-risk HPV genotypes, reporting 6 individually plus pooled groups with extended genotyping, confirmed by NCQA to close CCS at home or in clinic.
See the full cervical program →
At-home fecal immunochemical testing detects hidden blood in the stool, a key early indicator of colorectal cancer. Simple, non-invasive, and completed at home.
At-home HbA1c measures average blood sugar over roughly three months, a triple-weighted measure in Medicare Advantage Star Ratings.
At-home eGFR and uACR testing supports the Kidney Health Evaluation for patients with diabetes, catching kidney disease earlier.
Our high-complexity lab also supports molecular and PCR diagnostics, including women's health and infectious disease panels.
Engagement, kits, logistics, lab, and reporting under one roof, instead of four or five vendors.
Consistent, real-time reporting and HEDIS supplemental data files across every measure.
Every program processed in our own high-complexity CLIA and COLA accredited laboratory.
Talk to us about consolidating your screening programs on one integrated platform.